FCGR3A and Miyoshi myopathy: Recently, it has been demonstrated in an ex-vivo assay that the CD16+ subset of monocytes is essential in DARA MM cells-killing activity and the inhibition of the anti-phagocytic signal CD47-SIRPα significantly improves the DARA effect mediated by CD16+ monocytes (49).